US 10,465,180 K1 (4,152nd)
	Factor IX polypeptide mutant, its uses and method for its production
Paolo Simioni
Assigned to UNIQURE BIOPHARMA B.V.
Trial No. IPR2021-00928, May 11, 2021
Inter Partes Review Certificate for Patent 10,465,180, issued Nov. 5, 2019, Appl. No. 15/989,665, May 25, 2018
Inter Partes Review Certificate issued Oct. 16, 2025